Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
about
Graft-versus-host disease biomarkers: omics and personalized medicineDominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection.Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant.Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults.Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant RecipientsIntestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseAssociation between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cellsRobust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomesImmune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Impact of HLA in cord blood transplantation outcomes.Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab.Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaAdvances in umbilical cord blood transplant: an overview of the 12th International Cord Blood Symposium, San Francisco, 5-7 June 2014.Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies.Estimation of size of cord blood inventory based on high-resolution typing of HLAs.Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
P2860
Q26824540-06EE5590-AC29-45FE-894B-FAF26315C03AQ33456839-22B87170-8A34-4FC6-B292-B9E863D11B54Q34463602-4A816B52-DBB5-4C73-B157-615C453ED0DEQ34802425-25224AF0-7B3D-4CF4-9C31-ACC8D804EEC2Q35200303-CC9038F2-8E9F-4077-B109-97EEF17AA17BQ35514288-95AE68AE-1EA5-4136-8473-DBFE9CFB4C83Q35533371-A7F6355E-3164-463B-8800-E300D2E07FA3Q35692767-DC89B8A8-A0C6-48F9-BA23-23730E6CA396Q35738453-0ED8AA66-4990-4ED2-8E65-7A5BF1D0AD59Q35892249-3DAE7B29-A0D8-4EFC-BF19-EBEE5227A071Q36157327-A212F8C6-D6BC-4EB0-9711-DFF9315400A8Q36197984-1497F62D-9E11-408C-8C90-2942D0562FE6Q36355144-807CC67C-4C55-4EA6-BF91-9CC4A702A47CQ36622322-69409E23-2CEA-4A5C-A1F7-E5676DAEACBCQ36623408-70CA400A-8C1A-4170-BF0E-B85475F32191Q36675937-6EC677FD-6160-4E6C-9771-A2BB996E0820Q37675185-C8AA563A-5CA8-4F67-966C-E57B0B2DD852Q38728525-43240671-D59D-4C3D-9FB8-68341144D329Q38747929-FA9AD7D8-F5E2-4A3C-B19B-C21C10608386Q38802750-F601877C-9090-4596-A8C0-39DF2F342011Q40575535-609147C8-458B-4DA9-8011-E00DBE31198FQ40618397-28D0019D-02D8-46BA-8E2E-32579369D016Q41411372-5AEEA2C4-CE82-428C-B070-48596BA99A4AQ43668394-78062486-63D9-4806-816C-F49DD6F92D26Q44059940-247A43CC-EDBB-49A0-92F1-98BCE0AFF8ADQ47174568-768832AA-A296-4514-B68F-1F20D1031594Q47865655-3AE13D00-E3D5-4F83-9409-0654FF5DA542Q56576062-CF6947CA-528B-471F-9609-0D18C970E485
P2860
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Graft-versus-host disease afte ...... g unit-to-recipient HLA match.
@en
type
label
Graft-versus-host disease afte ...... g unit-to-recipient HLA match.
@en
prefLabel
Graft-versus-host disease afte ...... g unit-to-recipient HLA match.
@en
P2093
P2860
P1476
Graft-versus-host disease afte ...... ng unit-to-recipient HLA match
@en
P2093
A Gonzales
A Jakubowski
A M Hanash
A Scaradavou
C E Stevens
E B Papadopoulos
H Castro-Malaspina
J D Goldberg
P2860
P304
P356
10.1016/J.BBMT.2013.02.008
P577
2013-02-14T00:00:00Z